Elongin B-mediated epigenetic alteration of viral chromatin correlates with efficient human cytomegalovirus gene expression and replication

mBio

Volumn 2, Issue 2, 2011, Pages

  Hwang, Jiwon ^a   Saffert, Ryan T ^a   Kalejta, Robert F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAXX PROTEIN; DOUBLE STRANDED DNA; ELONGIN B; ELONGIN C; HISTONE H2B; IMMEDIATE EARLY PROTEIN; MESSENGER RNA; PROTEIN PP65; PROTEIN PP71; RNA POLYMERASE II; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN; VIRUS RNA; ELONGIN; TRANSCRIPTION FACTOR;

ARTICLE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA REPLICATION; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; HUMAN CYTOMEGALOVIRUS; NONHUMAN; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; UBIQUITINATION; VIRION; VIRUS GENOME; VIRUS REPLICATION; CELL LINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; VIROLOGY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 5;

CELL LINE; CHROMATIN; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, VIRAL; HUMANS; TRANSCRIPTION FACTORS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 79956119050     PISSN: None     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00023-11     Document Type: Article

References (63)

1. Aso T, Lane WS, Conaway JW, Conaway RC. 1995. Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II. Science 269: 1439-1443.
2. Shilatifard A, Conaway RC, Conaway JW. 2003. The RNA polymerase II elongation complex. Annu. Rev. Biochem. 72:693-715.
3. Yasukawa T, et al. 2008. Mammalian elongin A complex mediates DNAdamage-induced ubiquitylation and degradation of Rpb1. EMBO J. 27: 3256-3266.
4. Harreman M, et al. 2009. Distinct ubiquitin ligases act sequentially for RNA polymerase II polyubiquitylation. Proc. Natl. Acad. Sci. U. S. A. 106:20705-20710.
5. Li XS, Trojer P, Matsumura T, Treisman JE, Tanese N. 2010. Mammalian SWI/SNF-A subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B. Mol. Cell. Biol. 30:1673-1688.
6. Chandrasekharan MB, Huang F, Sun ZW. 2009. Ubiquitination of histone H2B regulates chromatin dynamics by enhancing nucleosome stability. Proc. Natl. Acad. Sci. U. S. A. 106:16686-16691.
7. Weake VM, Workman JL. 2008. Histone ubiquitination: triggering gene activity. Mol. Cell 29:653-663.
8. Minsky N, et al. 2008. Monoubiquitinated H2B is associated with the transcribed region of highly expressed genes in human cells. Nat. Cell Biol. 10:483-488.
9. Espinosa JM. 2008. Histone H2B ubiquitination: the cancer connection. Genes Dev. 22:2743-2749.
10. Hartzog GA, Quan TK. 2008. Just the FACTs: histone H2B ubiquitylation and nucleosome dynamics. Mol. Cell 31:2-4.
11. Fleming AB, Kao CF, Hillyer C, Pikaart M, Osley MA. 2008. H2B ubiquitylation plays a role in nucleosome dynamics during transcription elongation. Mol. Cell 31:57-66.
12. Pavri R, et al. 2006. Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II. Cell 125:703-717.
13. Querido E, et al. 2001. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a cullincontaining complex. Genes Dev. 15:3104-3117.
14. Ohh M, et al. 2000. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2:423-427.
15. Huh K, et al. 2007. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J. Virol. 81: 9737-9747.
16. Yu X, et al. 2003. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302:1056-1060.
17. Zhang JG, et al. 1999. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc. Natl. Acad. Sci. U. S. A. 96: 2071-2076.
18. Lonergan KM, et al. 1998. Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2. Mol. Cell. Biol. 18:732-741.
19. Kamura T, et al. 1998. The elongin BC complex interacts with the con-served SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12:3872-3881.
20. Deshaies RJ, Joazeiro CA. 2009. RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 78:399-434.
21. Isaacson MK, Ploegh HL. 2009. Ubiquitination, ubiquitin-like modifiers, and deubiquitination in viral infection. Cell Host Microbe 5:559-570.
22. Mocarski ES, Shenk T, Pass RF. 2007. Cytomegaloviruses, p. 2701-2772. In Knipe DM, Howley PM (ed.), Fields virology, 5th ed., vol. 2. Lippincott Williams and Wilkins, Philadelphia, PA.
23. Leung AK, Sauve RS, Davies HD. 2003. Congenital cytomegalovirus infection. J. Natl. Med. Assoc. 95:213-218.
24. Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA. 1992. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr. Infect. Dis. J. 11:93-99.
25. Lunardi C, Bason C, Corrocher R, Puccetti A. 2005. Induction of endothelial cell damage by hCMV molecular mimicry. Trends Immunol. 26:19-24.
26. Gandhi MK, Khanna R. 2004. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect. Dis. 4:725-738.
27. Cinatl J, Vogel JU, Kotchetkov R, Doerr HW. 2004. Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression. FEMS Microbiol. Rev. 28:59-77.
28. Söderberg-Nauclér C. 2006. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J. Intern. Med. 259:219-246.
29. Koch S, Solana R, Dela Rosa O, Pawelec G. 2006. Human cytomegalovirus infection and T cell immunosenescence: a mini review. Mech. Ageing Dev. 127:538-543.
30. Saffert RT, Kalejta RF. 2006. Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J. Virol. 80:3863-3871.
31. Tavalai N, Stamminger T. 2008. New insights into the role of the subnuclear structure ND10 for viral infection. Biochim. Biophys. Acta 1783: 2207-2221.
32. Kalejta RF. 2008. Tegument proteins of human cytomegalovirus. Microbiol. Mol. Biol. Rev. 72:249-265.
33. Kalejta RF, Shenk T. 2003. Proteasome-dependent, ubiquitinindependent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc. Natl. Acad. Sci. U. S. A. 100: 3263-3268.
34. Hwang J, Kalejta RF. 2007. Proteasome-dependent, ubiquitinindependent degradation of Daxx by the viral pp71 protein in human cytomegalovirus-infected cells. Virology 367:334-338.
35. Saffert RT, Kalejta RF. 2008. Promyelocytic leukemia-nuclear body proteins: herpesvirus enemies, accomplices, or both? Future Virol. 3:265-277.
36. Bresnahan WA, Shenk TE. 2000. UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells. Proc. Natl. Acad. Sci. U. S. A. 97:14506-14511.
37. Cantrell SR, Bresnahan WA. 2005. Interaction between the human cytomegalovirus UL82 gene product (pp71) and hDaxx regulates immediateearly gene expression and viral replication. J. Virol. 79:7792-7802.
38. Hofmann H, Sindre H, Stamminger T. 2002. Functional interaction between the pp71 protein of human cytomegalovirus and the PMLinteracting protein human Daxx. J. Virol. 76:5769-5783.
39. Saffert RT, Kalejta RF. 2007. Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro. J. Virol. 81:9109-9120.
40. Rüger B, et al. 1987. Primary structure and transcription of the genes coding for the two virion phosphoproteins pp65 and pp71 of human cytomegalovirus. J. Virol. 61:446-453.
41. Jones JC, et al. 2004. C-terminal repeat domain kinase I phosphorylates Ser2 and Ser5 of RNA polymerase II C-terminal domain repeats. J. Biol. Chem. 279:24957-24964.
42. Tamrakar S, Kapasi AJ, Spector DH. 2005. Human cytomegalovirus infection induces specific hyperphosphorylation of the carboxyl-terminal domain of the large subunit of RNA polymerase II that is associated with changes in the abundance, activity, and localization of cdk9 and cdk7. J. Virol. 79:15477-15493.
43. Browne EP, Wing B, Coleman D, Shenk T. 2001. Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. J. Virol. 75:12319-12330.
44. Zhu B, et al. 2005. Monoubiquitination of human histone H2B: the factors involved and their roles in HOX gene regulation. Mol. Cell 20: 601-611.
45. Kim J, Hake SB, Roeder RG. 2005. The human homolog of yeast BRE1 functions as a transcriptional coactivator through direct activator interactions. Mol. Cell 20:759-770.
46. Shema E, et al. 2008. The histone H2B-specific ubiquitin ligase RNF20/ hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression. Genes Dev. 22:2664-2676.
47. Bechtel JT, Shenk T. 2002. Human cytomegalovirus UL47 tegument protein functions after entry and before immediate-early gene expression. J. Virol. 76:1043-1050.
48. Brody Y, et al. 2011. The in vivo kinetics of RNA polymerase II elongation during co-transcriptional splicing. PLoS Biol. 9:e1000573.
49. Saunders A, Core LJ, Lis JT. 2006. Breaking barriers to transcription elongation. Nat. Rev. Mol. Cell Biol. 7:557-567.
50. Sinclair J. 2009. Chromatin structure regulates human cytomegalovirus gene expression during latency, reactivation and lytic infection. Biochim. Biophys. Acta 1799:286-295.
51. Paulus C, Nitzsche A, Nevels M. 2010. Chromatinisation of herpesvirus genomes. Rev. Med. Virol. 20:34-50.
52. Zhang G, et al. 2007. Antisense transcription in the human cytomegalovirus transcriptome. J. Virol. 81:11267-11281.
53. Murphy E, Shenk T. 2008. Human cytomegalovirus genome. Curr. Top. Microbiol. Immunol. 325:1-19.
54. Somesh BP, et al. 2005. Multiple mechanisms confining RNA polymerase II ubiquitylation to polymerases undergoing transcriptional arrest. Cell 121:913-923.
55. Fraser KA, Rice SA. 2005. Herpes simplex virus type 1 infection leads to loss of serine-2 phosphorylation on the carboxyl-terminal domain ofRNA polymerase II. J. Virol. 79:11323-11334.
56. Dai-Ju JQ, Li L, Johnson LA, Sandri-Goldin RM. 2006. ICP27 interacts with the C-terminal domain of RNA polymerase II and facilitates its recruitment to herpes simplex virus 1 transcription sites, where it undergoes proteasomal degradation during infection. J. Virol. 80:3567-3581.
57. Sasagawa Y, Kikuchi K, Dazai K, Higashitani A. 2005. Caenorhabditis elegans elongin BC complex is essential for cell proliferation and chromosome condensation and segregation during mitosis and meiotic division II. Chromosome Res. 13:357-375.
58. Selth LA, Sigurdsson S, Svejstrup JQ. 2010. Transcript elongation by RNA polymerase II. Annu. Rev. Biochem. 79:271-293.
59. Venter JC, et al. 2001. The sequence of the human genome. Science 291:1304-1351.
60. Nitzsche A, Paulus C, Nevels M. 2008. Temporal dynamics of cytomegalovirus chromatin assembly in productively infected human cells. J. Virol. 82:11167-11180.
61. Hwang J, Kalejta RF. 2009. Human cytomegalovirus protein pp71 induces Daxx SUMOylation. J. Virol. 83:6591-6598.
62. + cells. J. Virol. 84:5594-5604.
63. Kuo MH, Allis CD. 1999. In vivo cross-linking and immunoprecipitation for studying dynamic protein:DNA associations in a chromatin environment. Methods 19:425-433.